Home » Blocked From Selling Off-Brand Ozempic, Telehealth Startups Embrace a Less Effective Drug

Blocked From Selling Off-Brand Ozempic, Telehealth Startups Embrace a Less Effective Drug

Blocked From Selling Off-Brand Ozempic, Telehealth Startups Embrace a Less Effective Drug

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 medication injected daily instead of weekly. WIRED Read More 

 As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 medication injected daily instead of weekly.